semaglutide vs tirzepatide weight loss efficacy outperformed weight-loss drug results in real world patients, study shows Percentage body weight loss with

Current research shows that semaglutide does not reduce the effectiveness of oral contraceptives

Retatrutide does not hold MHRA marketing authorisation and is not licensed for use in the UK outside of regulated clinical trials

The side effect profiles for semaglutide and tirzepatide are better characterized because both medications have been on the market longer

Key resources include the bacteriostatic water mixing guide for tirzepatide and the equivalent guide for retatrutide

Injecting Zepbound is a once-weekly process that patients can manage at home

while some find biweekly dosing better than nothing for budget reasons, many ultimately return to weekly dosing when they can afford it